Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.
Jay W. Marks, MD, is a board-certified internist and gastroenterologist. He graduated from Yale University School of Medicine and trained in internal medicine and gastroenterology at UCLA/Cedars-Sinai Medical Center in Los Angeles.
Individuals who are allergic to NSAIDs
of breath when given an NSAID. People with
are at a higher risk for experiencing serious allergic reaction to NSAIDs.
Individuals with a serious allergy to one NSAID are likely to experience a
similar reaction to a different NSAID.
Meloxicam may cause fluid retention and swelling (edema). It should be used
cautiously in people with heart failure.
Meloxicam may reduce kidney function. Therefore, it should not be used in
people with severe kidney failure. It should be used cautiously in the elderly,
people with heart failure, liver dysfunction, and those taking diuretics,
ACE-inhibitors, or angiotensin II antagonists.
Serious skin reactions such as exfoliative dermatitis, Stevens- Johnson
syndrome, and toxic epidermal necrolysis (TEN) may occur without warning.
NSAIDs (except low dose aspirin) may increase the risk of potentially fatal
stroke, and related conditions in people with or without heart disease or
risk factors for heart disease. The increased risk of heart attack or stroke may
occur as early as the first week of use and the risk may increase with longer
use and is higher in patients who have underlying risk factors for heart and
blood vessel disease. Therefore, NSAIDs should not be used for the treatment of
pain resulting from
coronary artery bypass graft (CABG) surgery.
Central nervous system effects including drowsiness, dizziness, and blurred
vision may occur in patients who are taking an NSAIDs.